Investor expectations of limited future growth might have le...
Investor expectations of limited future growth might have led to Tonghua Dongbao Pharmaceutical's lower P/E ratio. The reduced possibility of significant share price increases speaks to the company's dimmed earnings outlook, which also contributes to the low P/E.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000190e799f6ca7bd.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment